#ProstateCancer is the second most frequent cancer and the fifth leading cause of cancer death among men. Since it is a slow growing tumour, doctors suggest that an early detection leads to better chances of successful treatment.
Prostate-Specific Antigen (PSA) test has been proven to be an efficient, easy, and cost-effective method of screening for prostate cancer. Here’s our research study reinforcing the importance of PSA screening test, which has been published in the International Journal of Health Sciences and Research. This study showed a statistical correlation of age and PSA with prostatic carcinoma identified through prostatic core needle biopsies. The risk of cancer is minimal with a PSA less than 4 ng/ml whereas an elevated PSA is associated with pathology and hence even a borderline elevation should not be ignored.
We congratulate and thank all our doctors Kunjal Lila, Dr. Kirti Chadha, Dr. Shaikhali M Barodawala, Dr. Vikas S Kavishwar and Dr. Anuradha K Murthy for contributing to this research study. #ProstateCancer
Posted On: 06 May 2022 5:58 PM